250 related articles for article (PubMed ID: 9134635)
41. Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia.
Raffoux E; Rousselot P; Poupon J; Daniel MT; Cassinat B; Delarue R; Taksin AL; Réa D; Buzyn A; Tibi A; Lebbé G; Cimerman P; Chomienne C; Fermand JP; de Thé H; Degos L; Hermine O; Dombret H
J Clin Oncol; 2003 Jun; 21(12):2326-34. PubMed ID: 12805334
[TBL] [Abstract][Full Text] [Related]
42. Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group.
Ortega JJ; Madero L; Martín G; Verdeguer A; García P; Parody R; Fuster J; Molines A; Novo A; Debén G; Rodríguez A; Conde E; de la Serna J; Allegue MJ; Capote FJ; González JD; Bolufer P; González M; Sanz MA;
J Clin Oncol; 2005 Oct; 23(30):7632-40. PubMed ID: 16234524
[TBL] [Abstract][Full Text] [Related]
43. Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: clinicopathological and molecular features of a pilot study.
Kwong YL; Au WY; Chim CS; Pang A; Suen C; Liang R
Am J Hematol; 2001 Apr; 66(4):274-9. PubMed ID: 11279639
[TBL] [Abstract][Full Text] [Related]
44. [The role of cytokines on hyperleukocytosis associated with acute promyelocytic leukemia induced by all-trans retinoic acid therapy].
Hino K; Nakamaki T
Rinsho Ketsueki; 1996 Sep; 37(9):770-6. PubMed ID: 8914460
[TBL] [Abstract][Full Text] [Related]
45. Use of all-trans retinoic acid to treat acute promyelocytic leukemia: a case with very severe features at the onset in Nicaragua.
Flores A; Malta A; Pacheco C; Baez F; Ocampo E; Conter V; Masera G; Biondi A; Rovelli A
Med Pediatr Oncol; 1996 Apr; 26(4):258-60. PubMed ID: 8600338
[TBL] [Abstract][Full Text] [Related]
46. [Studies on the fragments of FDP in 3 patients with DIC associated with acute promyelocytic leukemia].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1993 Jun; 41(6):719-25. PubMed ID: 8361040
[TBL] [Abstract][Full Text] [Related]
47. [Differentiation therapy of acute promyelocytic leukemia with all-trans retinoic acid].
Ohno R
Gan To Kagaku Ryoho; 1993 Feb; 20(2):189-93. PubMed ID: 8434955
[TBL] [Abstract][Full Text] [Related]
48. Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia.
Giordano P; Molinari AC; Del Vecchio GC; Saracco P; Russo G; Altomare M; Perutelli P; Crescenzio N; Santoro N; Marchetti M; De Mattia D; Falanga A
Am J Hematol; 2010 May; 85(5):325-30. PubMed ID: 20425794
[TBL] [Abstract][Full Text] [Related]
49. Rapid improvement of coagulopathy by all-trans retinoic acid in acute promyelocytic leukemia.
Kawai Y; Watanabe K; Kizaki M; Murata M; Kamata T; Uchida H; Moriki T; Yokoyama K; Tokuhira M; Nakajima H
Am J Hematol; 1994 Jul; 46(3):184-8. PubMed ID: 8192147
[TBL] [Abstract][Full Text] [Related]
50. [Oral All-transretinoic acid administration in intubated patients with acute promyelocytic leukemia].
Bargetzi MJ; Tichelli A; Gratwohl A; Speck B
Schweiz Med Wochenschr; 1996 Nov; 126(45):1944-5. PubMed ID: 8946598
[TBL] [Abstract][Full Text] [Related]
51. [Induction of hematologic remission in a patient with acute promyelocytic leukemia through the therapeutic use of trans-retinoic acid].
Skotnicki AB; Stoch A; Sacha T; Nowak WS
Acta Haematol Pol; 1994; 25(1):69-74. PubMed ID: 8209619
[TBL] [Abstract][Full Text] [Related]
52. [Complete remission of acute promyelocytic leukemia resisting all-trans retinoic acid of one case treated by tanshinone II A].
Yang YM; Liu T
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Nov; 37(6):965-7. PubMed ID: 17236602
[TBL] [Abstract][Full Text] [Related]
53. [A "retinoic acid syndrome" observed in two cases of acute promyelocytic leukemia].
Horikoshi A; Sawada S; Aiso M; Kawamura M; Iizuka Y; Takeuchi J; Ohshima T; Horie T; Naoe T; Ohno R
Rinsho Ketsueki; 1993 Sep; 34(9):1044-9. PubMed ID: 8230749
[TBL] [Abstract][Full Text] [Related]
54. [Childhood acute promyelocytic leukemia treated with all-trans retinoic acid].
Hatae Y; Nakadate H; Iizuka S; Takeda T; Shikano T; Imaizumi M
Rinsho Ketsueki; 1996 Dec; 37(12):1410-5. PubMed ID: 8997131
[TBL] [Abstract][Full Text] [Related]
55. The pathophysiology and treatment of hemorrhagic syndrome of acute promyelocytic leukemia.
Rodeghiero F; Castaman G
Leukemia; 1994; 8 Suppl 2():S20-6. PubMed ID: 7815832
[TBL] [Abstract][Full Text] [Related]
56. [Responses to surgical stress in blood coagulation and fibrinolysis, platelet counts and thromboxane B2 after esophageal cancer operation].
Shinohara M; Kurokawa H; Yoshihara Y; Kokubu S; Kusano T; Horie K; Murakami N; Nagai K; Nara N
Rinsho Byori; 1997 Feb; 45(2):179-84. PubMed ID: 9121003
[TBL] [Abstract][Full Text] [Related]
57. Addition of Arsenic Trioxide into Induction Regimens Could Not Accelerate Recovery of Abnormality of Coagulation and Fibrinolysis in Patients with Acute Promyelocytic Leukemia.
Zhang Y; Wu S; Luo D; Zhou J; Li D
PLoS One; 2016; 11(1):e0147545. PubMed ID: 26812490
[TBL] [Abstract][Full Text] [Related]
58. [A study of tissue factor expression and hemostatic molecular markers in patients with acute promyelocytic leukemia].
Wu F; Wang X; Zhao W; Wang H; Shen Z
Zhonghua Nei Ke Za Zhi; 2001 Jan; 40(1):36-9. PubMed ID: 11798557
[TBL] [Abstract][Full Text] [Related]
59. Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia.
Kim DY; Lee JH; Lee JH; Kim SD; Lim SN; Choi Y; Lee YS; Kang YA; Seol M; Jeon M; Kim JY; Lee KH; Lee YJ; Lee KH
Leuk Res; 2011 Feb; 35(2):152-8. PubMed ID: 20554322
[TBL] [Abstract][Full Text] [Related]
60. Pediatric acute promyelocytic leukemia: all-transretinoic acid therapy in a Brazilian pediatric hospital.
da Costa Moraes CA; Trompieri NM; Cavalcante Felix FH
J Pediatr Hematol Oncol; 2008 May; 30(5):387-90. PubMed ID: 18458575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
